Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda RolloutMerck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
Man Loses Most of His Penis After Filler Procedure—Doctor Blames the PatientIn a harrowing tale that has caught the attention of many, a man faced devastating consequences after undergoing a penile filler procedure.
Top 10 Essential Shots You Need Beyond COVID-19Don't forget non-COVID vaccines! Protect against diseases like Hepatitis B, Cervical Cancer, and Meningococcal Infection.
Must-Reads
1
Shaw Prize winner Baumeister on breakthroughs that changed cell imaging
LATEST
2
Coach-athlete interaction at marathon finish sparks online debate
LATEST
3
Seoul shares snap 2-day drop on hopes for rate cut, eased AI fear; won rebounds
LATEST
4
Hanwha revamps US investment arm for defense push
LATEST
5
S. Korea asks Lone Star to reimburse legal costs after winning annulment in investor dispute
Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout Merck plans to launch a subcutaneous Keytruda for cancer treatment in the US, awaiting FDA approval by September 23.
Man Loses Most of His Penis After Filler Procedure—Doctor Blames the Patient In a harrowing tale that has caught the attention of many, a man faced devastating consequences after undergoing a penile filler procedure.
Top 10 Essential Shots You Need Beyond COVID-19 Don't forget non-COVID vaccines! Protect against diseases like Hepatitis B, Cervical Cancer, and Meningococcal Infection.
Hot Topics